Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Titilayo O Ilori"'
Autor:
Titilayo O Ilori, Nosayaba Enofe, Anju Oommen, Jason Cobb, Jose Navarrete, Demilade A Adedinsewo, Oluwatobiloba Oshikoya, Helene Fevrier, Alton B Farris, Laura Plantinga, Akinlolu O Ojo
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0157485 (2016)
Lupus nephritis (LN) is a serious organ manifestation of systemic lupus erythematosus. Histologic overlap is relatively common in the six pathologic classes (I to VI) of LN. For example, mixed proliferative LN (MPLN) often includes features of classe
Externí odkaz:
https://doaj.org/article/fa853204f09246e1b843ed603bbac0a5
Autor:
Xiaoqian eQian, Xuechen eLi, Titilayo O Ilori, Janet D. Klein, Rebecca P Hughey, Cong-jun eLi, Abdel A Alli, Zhengyu eGuo, Peng eYu, Xiang eSong, Guangping eChen
Publikováno v:
Frontiers in Physiology, Vol 6 (2015)
The UT-A1 urea transporter is crucial to the kidney’s ability to generate concentrated urine. Native UT-A1 from kidney inner medulla (IM) is a heavily glycosylated protein with two glycosylation forms of 97 and 117 kDa. In diabetes, UT-A1 protein a
Externí odkaz:
https://doaj.org/article/653c6cd45f3d4297b5fb33925d6fb5dc
Autor:
Xiumei Hong, Avi Z. Rosenberg, Jurgen Heymann, Teruhiko Yoshida, Sushrut S. Waikar, Titilayo O. Ilori, Guoying Wang, Heather Rebuck, Colleen Pearson, Mei‐Cheng Wang, Cheryl A. Winkler, Jeffrey B. Kopp, Xiaobin Wang
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 22 (2023)
Background Pregnancy complications are risk factors for cardiovascular disease (CVD). Little is known about the role of renal biomarkers measured shortly after delivery, individually or in combination with pregnancy complications, in predicting subse
Externí odkaz:
https://doaj.org/article/0cd0fab5acf542fdadd9fb0d8b5990be
Autor:
Titilayo O. Ilori, Marquita S. Brooks, Parin N. Desai, Katharine L. Cheung, Suzanne E. Judd, Deidra C. Crews, Mary Cushman, Cheryl A. Winkler, Michael G. Shlipak, Jeffrey B. Kopp, Rakhi P. Naik, Michelle M. Estrella, Orlando M. Gutiérrez, Holly Kramer
Publikováno v:
Kidney Medicine, Vol 5, Iss 5, Pp 100621- (2023)
Rationale & Objective: Dietary factors may impact inflammation and interferon production, which could influence phenotypic expression of Apolipoprotein1 (APOL1) genotypes. We investigated whether associations of dietary patterns with kidney outcomes
Externí odkaz:
https://doaj.org/article/47072cb1f6574f0f9bf2b459a2d54c41
Autor:
Timothy O. Olanrewaju, Charlotte Osafo, Yemi R. Raji, Manmak Mamven, Samuel Ajayi, Titilayo O. Ilori, Fatiu A. Arogundade, Ifeoma I. Ulasi, Rasheed Gbadegesin, Rulan S. Parekh, Bamidele Tayo, Adebowale A. Adeyemo, Olanrewaju T. Adedoyin, Adindu A. Chijioke, Clement Bewaji, Diederick E. Grobbee, Peter J. Blankestijn, Kerstin Klipstein-Grobusch, Babatunde L. Salako, Dwomoa Adu, Akinlolu O. Ojo
Publikováno v:
Kidney International Reports. 8:658-666
Autor:
Titilayo O. Ilori, Adaobi Solarin, Mamven Manmak, Yemi R. Raji, Rotimi Braimoh, Edward Kwakyi, Theophilus Umeizudike, Titilope Ajepe, Omotoso Bolanle, Nanna Ripiye, Ernestina Eduful, Temitayo Adebile, Chinwuba Ijeoma, Amisu A. Mumuni, Jessica Chern, Morenikeji Akinpelu, Ifeoma Ulasi, Fatiu Arogundade, Babatunde L. Salako, Rasheed Gbadegesin, Rulan S. Parekh, Josée Dupuis, Christiana O. Amira, Dwomoa Adu, Cheryl A.M. Anderson, Akinlolu Ojo, Sushrut S. Waikar
Publikováno v:
Kidney international reports, vol 8, iss 4
Kidney Int Rep
Kidney Int Rep
INTRODUCTION: Diet, chronic kidney disease (CKD), and Apolipoprotein L1 (APOL1) (DCA) Study is examining the role of dietary factors in CKD progression and APOL1 nephropathy. We describe enrollment and retention efforts and highlight facilitators and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0e1a3bb8a8501d79616a9f71f29cf4b
https://escholarship.org/uc/item/97f3s5nm
https://escholarship.org/uc/item/97f3s5nm
Autor:
Xiumei Hong, Avi Z. Rosenberg, Jurgen Heymann, Teruhiko Yoshida, Sushrut S. Waikar, Titilayo O. Ilori, Guoying Wang, Heather Rebuck, Colleen Pearson, Mei-Cheng Wang, Cheryl A. Winkler, Jeffrey B. Kopp, Xiaobin Wang
Publikováno v:
medRxiv
Rationale & ObjectivePregnancy complications are risk factors for cardiovascular diseases (CVD). Little is known about the role of renal biomarkers measured shortly after delivery, individually or in combination with pregnancy complications, in predi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abf864731549c45b479210ce9c8da321
https://doi.org/10.1101/2023.03.14.23287276
https://doi.org/10.1101/2023.03.14.23287276
Autor:
Sushrut S. Waikar, Titilayo O. Ilori, Ashish Verma, Jing Liu, Insa M. Schmidt, Finnian R. Mc Causland, Maria Clarissa Tio, Felix Knauf
Publikováno v:
J Clin Endocrinol Metab
Context Abnormalities in calcium metabolism are common in chronic kidney disease (CKD). Diminished urinary calcium excretion may promote vascular calcification and increased urinary calcium excretion may lead to nephrolithiasis and nephrocalcinosis,
Autor:
Titilayo O. Ilori, Jing Liu, Aylin R. Rodan, Ashish Verma, Katherine T. Mills, Jiang He, Cheryl A. Winkler, Josée Dupuis, Cheryl A.M. Anderson, Sushrut S. Waikar
Publikováno v:
Clinical journal of the American Society of Nephrology : CJASN. 17(10)
Progressive CKD in Black individuals is strongly associated with polymorphisms in theWe analyzed 1399 self-identified Black participants enrolled in the Chronic Renal Insufficiency Cohort from April 2003 to September 2008. Exposures were calibrated 2
Autor:
Titilayo O. Ilori, Amanda Sokan, Tejo Vemulapalli, Eric Reiman, Usha Menon, Emma Viera, Akinlolu Ojo, Jason H. Karnes, Jillian Wilson, Tammy Ojo, Cecilia Rosales, Francisco A. Moreno, John E. Ehiri, Rachele S. Peterson, Sara C. StimsonRiahi, Elizabeth Calhoun, Andreas A. Theodorou
Publikováno v:
Clinical and Translational Science, Vol 13, Iss 4, Pp 685-692 (2020)
Clinical and Translational Science
Clinical and Translational Science
Clinical trials and cohort studies are required to meet target recruitment of study participants within stipulated timelines, especially when the priority is to include populations traditionally unrepresented in biomedical research. By the third quar